Latest news
Loading news…
DeuterOncology is a preclinical-stage biotech company.
DeuterOncology on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
DeuterOncology was acquired by Pathos in 2026.
Total Funding
$6.11M
Funding Rounds
2
Last Funding
Acquisitions
0
Monthly Visits
Contacts
1
About DeuterOncology
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Geel, Antwerpen, Belgium
DeuterOncology Funding Rounds
2 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–2 of 2Show
Page 1 / 1
DeuterOncology Key People
Founder and CEO
1
professional contacts at DeuterOncology
Contact execs at DeuterOncology →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to DeuterOncology
Loading news…
FAQs about DeuterOncology
People who checked this page also checked these
Browse the full Acquirezy directory.